Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

BACKGROUND. Type 2 diabetes mellitus (T2DM) is associated with increased risk of colon cancer (CC), whereas metformin use seems to be protective. However, the impact of metformin use on the risk of death or disease recurrence after radical surgery for CC remains uncertain. MATERIALS AND METHODS. Thi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Vernieri, Claudio, Galli, Fabio, Ferrari, Laura, Marchetti, Paolo, Lonardi, Sara, Maiello, Evaristo, Iaffaioli, Rosario V., Zampino, Maria G., Zaniboni, Alberto, De Placido, Sabino, Banzi, Maria, Damiani, Azzurra, Ferrari, Daris, Rosati, Gerardo, Labianca, Roberto F., Bidoli, Paolo, Frassineti, Giovanni L., Nicolini, Mario, Pavesi, Lorenzo, Tronconi, Maria C., Buonadonna, Angela, Ferrario, Sabrina, Re, Giovanni Lo, Adamo, Vincenzo, Tamburini, Emiliano, Clerico, Mario, Giordani, Paolo, Leonardi, Francesco, Barni, Sandro, Ciarlo, Andrea, Cavanna, Luigi, Gori, Stefania, Cinieri, Saverio, Faedi, Marina, Aglietta, Massimo, Antista, Maria, Dotti, Katia F., Galli, Francesca, Di Bartolomeo, Maria
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Inc. 2019
Gaiak:
Gastrointestinal Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519752/
https://ncbi.nlm.nih.gov/pubmed/30606884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0442
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak